CRIS Current Research Information System

GATTI, MILO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.942
NA - Nord America 1.594
AS - Asia 451
AF - Africa 65
SA - Sud America 23
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.087
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.582
IT - Italia 1.005
SE - Svezia 242
DE - Germania 230
VN - Vietnam 168
IN - India 149
GB - Regno Unito 131
IE - Irlanda 100
CN - Cina 79
BG - Bulgaria 59
CH - Svizzera 43
TG - Togo 34
FI - Finlandia 33
FR - Francia 22
RU - Federazione Russa 17
CI - Costa d'Avorio 14
ES - Italia 14
CA - Canada 11
JO - Giordania 11
NG - Nigeria 11
PE - Perù 11
AU - Australia 10
AR - Argentina 9
PL - Polonia 9
NL - Olanda 7
AT - Austria 6
SG - Singapore 6
UA - Ucraina 6
IL - Israele 5
ZA - Sudafrica 5
BE - Belgio 4
HK - Hong Kong 4
TR - Turchia 4
HR - Croazia 3
ID - Indonesia 3
IR - Iran 3
JP - Giappone 3
RO - Romania 3
SM - San Marino 3
TW - Taiwan 3
UZ - Uzbekistan 3
BH - Bahrain 2
CL - Cile 2
DK - Danimarca 2
EU - Europa 2
GR - Grecia 2
PH - Filippine 2
BR - Brasile 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
MK - Macedonia 1
MY - Malesia 1
PA - Panama 1
PK - Pakistan 1
TH - Thailandia 1
UG - Uganda 1
Totale 4.087
Salva come PNG Salva come JPEG
Città #
Chandler 268
Bologna 174
Princeton 120
Ashburn 114
Southend 104
Dublin 100
Fairfield 99
Milan 95
Dong Ket 83
Rome 69
Redmond 60
Sofia 59
New York 39
Seattle 39
Lomé 34
Bern 33
Houston 31
Woodbridge 29
Berlin 28
Turin 28
Cambridge 27
Des Moines 27
Florence 24
Helsinki 23
Naples 23
Mumbai 22
Wilmington 22
San Diego 21
Bremen 20
Tappahannock 20
Boydton 19
Vicenza 17
Beijing 15
Abidjan 14
Lecce 13
Ann Arbor 12
Bühl 12
Genoa 12
Amman 11
Bari 10
Chicago 10
Lappeenranta 10
Lima 10
Los Angeles 10
Abeokuta 9
Cesena 9
Toronto 9
Catania 8
Forlì 8
Medford 8
Monselice 8
Warsaw 8
Bergamo 7
Catanzaro 7
London 7
Maranello 7
Melbourne 7
Modena 7
Olalla 7
Paris 7
Verona 7
Caserta 6
Duncan 6
Roveredo in Piano 6
Sala Bolognese 6
Sassari 6
Verdellino 6
Arcene 5
Augusta 5
Barcelona 5
Buenos Aires 5
Marratxí 5
Messina 5
Philadelphia 5
Reggio Emilia 5
Rufina 5
Shijiazhuang 5
Vienna 5
Budrio 4
Castel Maggiore 4
Cesano Boscone 4
Delhi 4
Desio 4
Esslingen am Neckar 4
Falls Church 4
Giv‘atayim 4
Monteforte Irpino 4
Mountain View 4
Mülheim 4
Noventa di Piave 4
Oderzo 4
Paternò 4
Pisa 4
Ravenna 4
Saint Petersburg 4
San Francisco 4
Treviso 4
Trieste 4
Venafro 4
Washington 4
Totale 2.319
Salva come PNG Salva come JPEG
Nome #
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system 201
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients 155
Advances in the therapy of bacterial bloodstream infections 129
Adaptive trials of new antimicrobials for infections with carbapenem-resistant, Gram-negative bacteria 104
Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics 104
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing 93
Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: Insight from a pharmacovigilance study 84
An Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by Pseudomonas aeruginosa and Acinetobacter baumannii in Critically Ill Adult Patients 84
Assessing the association between fluoroquinolones and emerging adverse drug reactions raised by regulatory agencies: An umbrella review 83
Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews 82
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 81
Impact of a newly established expert clinical pharmacological advice program based on TDM results in tailoring antimicrobial therapies hospital-wide in a tertiary university hospital: findings after the first-year of implementation 80
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams 79
A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric Settings 77
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance 76
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 75
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections 74
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 74
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase 72
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia 71
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis 70
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF) 69
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis 69
Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections 66
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 65
Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring 64
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems 63
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis 55
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems 55
Targeted Therapy of Severe Infections Caused by Staphylococcus aureus in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World Evidence 54
Janus kinase inhibitors and coronavirus disease (Covid)‐19: Rationale, clinical evidence and safety issues 54
Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime–Avibactam-Based Regimens: A Report of Two Cases 54
Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements 49
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections 48
Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System 48
Clinical efficacy of renal dosing adjustments of ceftazidime‐avibactam in patients affected by carbapenem‐resistant Gram‐negative infections: a systematic review and meta‐analysis of observational studies 47
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of bsis, cutis, and ciais caused by enterobacterales in critically ill adult patients 47
Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: Case series and large-scale pharmacovigilance analysis 47
Relationship Between Real-time TDM-guided Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam Monotherapy and Microbiologic Outcome in the Treatment of Critically Ill Children With Severe Documented Gram-negative Infections 46
Should the Clinical Pharmacologist Play a Role in the Multidisciplinary Team Managing Severe Necrotizing Soft-Tissue Infections? 42
Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization 42
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 42
Suboptimal drug exposure leads selection of different subpopulations of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae in a critically ill patient 41
Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept 39
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections 39
Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors 37
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis 36
Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study 35
Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19 33
Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies 32
Serious adverse events with tedizolid and linezolid: pharmacovigilance insights through the FDA adverse event reporting system 32
Drug Interactions with Contraceptives 32
Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography-Tandem Mass Spectrometry for Therapeutic Drug Monitoring 31
Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients 31
A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis 31
Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysis 30
Real-world use of dalbavancin in the era of empowerment of outpatient antimicrobial treatment: A careful appraisal beyond approved indications focusing on unmet clinical needs 28
Drug repurposing in the covid-19 era: Insights from case studies showing pharmaceutical peculiarities 28
Pharmacokinetic analysis investigating gentamicin dosing in a major burned patient complicated by septic shock 27
Evidence and current use of levosimendan in the treatment of heart failure: Filling the gap 27
Fluoroquinolones and Aortic Disease 27
Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem 26
Orthopaedic Implant-Associated Staphylococcal Infections: A Critical Reappraisal of Unmet Clinical Needs Associated with the Implementation of the Best Antibiotic Choice 26
The Cytokine Release Syndrome and/or the Proinflammatory Cytokines as Underlying Mechanisms of Downregulation of Drug Metabolism and Drug Transport: A Systematic Review of the Clinical Pharmacokinetics of Victim Drugs of this Drug-Disease Interaction Under Different Clinical Conditions 24
Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis 24
Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis 24
Liver Injury with Nintedanib: A Pharmacovigilance-Pharmacokinetic Appraisal 24
Clinical efficacy of cefiderocol-based regimens in patients affected by carbapenem-resistant Acinetobacter baumannii infections: a systematic review with meta-analysis 23
In vivo acquisition and risk of inter-species spread of blaKPC-3-plasmid from Klebsiella pneumoniae to Serratia marcescens in the lower respiratory tract 23
European List of Essential Medicines for Medical Education: A protocol for a modified Delphi study 23
Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug Monitoring 22
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections 22
Fast and Sensitive Analysis of Cefiderocol in Human Plasma Microsamples by Liquid Chromatography-Isotope Dilution Tandem Mass Spectrometry for Therapeutic Drug Monitoring 22
Ibrutinib: from bench side to clinical implications 22
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia 21
Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach 21
Real-World Comparison of Isavuconazole and Voriconazole in Terms of the Need for Dosage Adjustments Guided by Clinical Pharmacological Advice During Primary Prophylaxis of Invasive Fungal Infections in Pediatric Patients with Hemato-Oncological Malignancies 20
Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant Staphylococcus aureus: A Retrospective Single-Centre Experience 19
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 18
Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis 18
Septic shock due to NSTI caused by Actinomyces Turicensis: the role of clinical pharmacology. Case report and review of the literature 18
Feasibility of FreeStyle Libre Flash Glucose Monitoring System in pregnant woman affected by type 1 diabetes 18
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF) 17
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients? 17
The impact of preservation fluid culture on graft site arteritis: a systematic review and metanalysis 16
FreeStyle Libre flash glucose monitoring system in pregnant woman with type 1 diabetes: a focus on accuracy 16
Intensive multidisciplinary management in critical care patients affected by severe necrotizing soft tissue infections: a cooperative method to improve the efficacy of treatment 13
Is a high baseline inflammatory burden the major driver in causing daptomycin-induced eosinophilic pneumonia and muscular toxicity? 11
Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration 11
Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study 11
The expert clinical pharmacological advice program for tailoring on real-time antimicrobial therapies with emerging TDM candidates in special populations: how the ugly duckling turned into a swan 10
Fast and Simple Liquid Chromatography-Isotope Dilution Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Dalbavancin in Long-Term Treatment of Subacute and/or Chronic Infections 10
Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for treating subacute and/or chronic staphylococcal infections 9
Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraemic complicated intra-abdominal infection: due to OXA-181-producing Klebsiella pneumoniae 9
Comment on: pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections 9
Therapeutic drug monitoring of ceftazidime/avibactam: why one leg is not enough to run 8
The European List of Key Medicines for Medical Education: A Modified Delphi Study 8
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections? 7
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria 7
Fast and Sensitive Analysis of Fosfomycin in Human Plasma Microsamples Using Liquid Chromatography-Tandem Mass Spectrometry for Therapeutic Drug Monitoring 7
Totale 4.344
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.339
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202065 0 0 0 0 0 0 0 21 9 7 2 26
2020/2021353 8 9 16 1 10 5 7 46 46 14 42 149
2021/20221.112 57 1 23 47 87 65 120 133 57 101 234 187
2022/20231.490 100 112 77 187 146 109 96 127 247 85 88 116
2023/20241.371 96 109 100 145 131 164 140 144 100 123 113 6
Totale 4.391